Skip to main content
SpringerLink
Log in

PHARMAC is expecting to save a record $NZ65 million through agreements with two companies over the β-blocker metoprolol

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. PHARMAC.Heart drug deals to save $65 million. Media Release: 7 Sep 2009. Available from: URL: http://www.pharmac.govt.nz

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

PHARMAC is expecting to save a record $NZ65 million through agreements with two companies over the β-blocker metoprolol. Pharmacoecon. Outcomes News 587, 11 (2009). https://doi.org/10.2165/00151234-200905870-00036

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905870-00036

Keywords

Search

Navigation